Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children

This publication has 14 references indexed in Scilit:

• Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia.
  Journal of Clinical Oncology, 1997
• Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: A randomized, double-blind, placebo-controlled trial
  The Journal of Pediatrics, 1996
• Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy.
  Journal of Clinical Oncology, 1996
• Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization.
  Proceedings of the National Academy of Sciences, 1994
• Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo
  Nature, 1994
• A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation
  Blood, 1994
• Recombinant Human Erythropoietin Therapy for Anemic Cancer Patients on Combination Chemotherapy
  JNCI Journal of the National Cancer Institute, 1993
• Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma
  JNCI Journal of the National Cancer Institute, 1991
• Prognostic significance of regional lymph node involvement in childhood extremity rhabdomyosarcoma
  Medical and Pediatric Oncology, 1990
• The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer
  British Journal of Cancer, 1989